Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Therapies for Alzheimer's disease.

× No keyword cloud information.

49 in total

1. Fragment-guided approach to incorporating structural information into a CoMFA study: BACE-1 as an example.

Authors: Lívia Barros Salum; Napoleão Fonseca Valadares
Journal: J Comput Aided Mol Des Date: 2010-07-27 Impact factor: 3.686

Review 2. Targeting NOX enzymes in the central nervous system: therapeutic opportunities.

Authors: Silvia Sorce; Karl-Heinz Krause; Vincent Jaquet
Journal: Cell Mol Life Sci Date: 2012-05-30 Impact factor: 9.261

3. Design, synthesis and structure-activity relationship (SAR) studies of 2,4-disubstituted pyrimidine derivatives: dual activity as cholinesterase and Aβ-aggregation inhibitors.

Authors: Tarek Mohamed; Xiaobei Zhao; Lila K Habib; Jerry Yang; Praveen P N Rao
Journal: Bioorg Med Chem Date: 2011-03-01 Impact factor: 3.641

4. Targeting age-related macular degeneration with Alzheimer's disease based immunotherapies: anti-amyloid-beta antibody attenuates pathologies in an age-related macular degeneration mouse model.

Authors: Jin-Dong Ding; John Lin; Brian E Mace; Rolf Herrmann; Patrick Sullivan; Catherine Bowes Rickman
Journal: Vision Res Date: 2007-09-20 Impact factor: 1.886

5. A computational view on the significance of E-ring in binding of (+)-arisugacin A to acetylcholinesterase.

Authors: Ziyad F Al-Rashid; Richard P Hsung
Journal: Bioorg Med Chem Lett Date: 2015-06-27 Impact factor: 2.823

6. Scutellarin protects against Aβ-induced learning and memory deficits in rats: involvement of nicotinic acetylcholine receptors and cholinesterase.

Authors: Li-li Guo; Zhi-zhong Guan; Yong-lin Wang
Journal: Acta Pharmacol Sin Date: 2011-10-10 Impact factor: 6.150

Review 7. Multi-target design strategies in the context of Alzheimer's disease: acetylcholinesterase inhibition and NMDA receptor antagonism as the driving forces.

Authors: Michela Rosini; Elena Simoni; Anna Minarini; Carlo Melchiorre
Journal: Neurochem Res Date: 2014-02-04 Impact factor: 3.996

Therapies for Alzheimer's disease.